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Abstract 
 
Pump thrombosis is a serious complication of continuous-flow left ventricular assist 
devices (LVAD).  Treatment options include medical thrombolysis, surgical pump 
exchange or urgent heart transplantation. We are reporting a case of pump 
thrombosis with active hemolysis and acute renal failure managed surgically by 
isolating the LVAD while awaiting renal recovery and donor heart availability.    
Keywords: Circulatory support devices, VAD complications, Heart failure, 
ventricular assist device 
 
Case Presentation 
 
A 43 year-old male with end-stage non-ischemic cardiomyopathy underwent 
Heartmate II LVAD implantation one year prior as bridge to decision (active 
cigarette smoking).  Subsequently he required pump exchange for pump 
thrombosis at 6 months post-implantation.  Two months following pump exchange, 
he again developed pump thrombosis and was transferred to our institution for 
consideration of urgent heart transplant listing.  On arrival he was 
hemodynamically stable.  Clinical exam demonstrated clear breath sounds 
bilaterally, harsh LVAD humming, palpable pulses in all extremities, jugular venous 
distension 4 cm above the clavicles and minimal peripheral edema.  Urine 
revealed gross hemolysis with dark Coca-cola discoloration.  Initial lab work 
showed an elevated lactate dehydrogenase (LDH) (714 U/L), mildly elevated NT 
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pro B-type natriuretic peptide (NT-proBNP) (1046pg/ml ) and serum creatinine of 
1.9 mg/dL.  Blood count demonstrated hemoglobin of 8 g/dL and hematocrit 
25.4%.  International normalized ratio (INR) on admission was 1.1 despite warfarin 
compliance.  ABO blood group was type A, and panel reactive antibody screen 
was 0% for class I and class II.   
LVAD interrogation revealed high power spikes and low pulsatility index.  
Transthoracic echocardiography showed a severely dilated left ventricle (left 
ventricular end diastolic diameter 6.8 cm) and left ventricular ejection fraction of 
20%.  A moderate-sized apical thrombus was identified at the LVAD inflow cannula 
(Figure 1).  Right heart catheterization demonstrated normal cardiac filling 
pressures (central venous pressure 3 mmHg, pulmonary artery pressure 21/8 
mmHg, pulmonary capillary wedge pressure 6 mmHg).  Fick cardiac output was 
measured as 6.11 L/min with cardiac index of 2.8 L/min/m2 and measured mixed 
venous oxygen saturation of 49%. Thermodilution cardiac output was measured at 
5.57 L/min.   
 
Figure 1a. Apical 4 chamber view of transthoracic echocardiogram showing 
the apical thrombus. 
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Figure 1b. Zoomed image with the dimension of the thrombus measuring 
2.6x1.2 cm. 
Intravenous anticoagulation was initiated with heparin infusion for pump 
thrombosis and hypercoagulability assessment was performed.  Despite 
therapeutic heparin anticoagulation, LDH levels continued to rise (3700 U/L) and 
the patient developed worsening acute renal injury (serum creatinine 4.37 mg/dL).  
Expedited heart transplant evaluation was undertaken, however due to worsening 
renal injury he required urgent intervention to eliminate ongoing hemolysis.  
 Decision was made to isolate the LVAD from circulation and maintain his 
hemodynamics with inotropic support.  The LVAD outflow graft was isolated and 
ligated via subxyphoid incision and the driveline was disconnected from the device 
controller.  Hemodynamically he remained stable on low dose milrinone infusion, 
and heparin anticoagulation was continued for the apical thrombus.  Following 
outflow graft ligation, urinary discoloration quickly cleared and renal clearance 
improved in the following 2 weeks (Figure 2) thereby permitting active listing for 
transplant.  He was stable without inotropes and subsequently underwent heart 
transplantation and LVAD explant 1 week later.   
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Figure 2. Creatinine trend from admission day 12/27/2015 till transplant date 
1/21/2016. Note that the creatinine level plateaued 12/28 and 12/29, the 
patient had LVAD ligation performed 12/29/15, and gradual kidney function 
recovery was noticed since. 
Discussion 
LVAD pump thrombosis is a major complication with increased incidence in recent 
years with continuous flow devices.  Emphasis has been placed on surgical 
technique and cannula malalignment as major contributing factors to the recent 
surge in Heartmate II LVAD device thrombosis [1].  Recently, Starling et al [2] 
summarized the experience of 3 US centers with 72 confirmed HeartMate II pump 
thromboses.  A significant 6-month actuarial mortality (48.2%) was noted in those 
patients managed medically without heart transplant or pump exchange, 
underscoring the importance of surgical intervention.  Treatment of pump 
thrombosis can include VAD exchange or explant, heart transplantation, or 
medical thrombolysis depending on the clinical presentation and patient candidacy 
for transplantation [3].  
In the case presented, LVAD ligation was felt to be the most feasible option to 
eliminate ongoing hemolysis and permit renal recovery for transplant listing, 
considering the stable hemodynamics and appearance of adequate cardiac 
function on transthoracic echocardiogram.   The alternative option of repeat pump 
exchange was complicated by the extent of left ventricular thrombus and concern 
of cannula malalignment that precipitated the repeated thrombosis.  The feasibility 
of our approach as a short-term intervention hinged upon our patient being non-
sensitized with preformed antibodies thereby facilitating donor heart matching.   
LVAD outflow graft ligation has not been previously described for the management 
of pump related hemolysis.  Baldwin et al [4] described various HeartMate II 
explant options in the setting of left ventricular recovery in which the technique of 
outflow graft ligation has been successfully demonstrated.  Alternatively, driveline 
transection also was reported as a surgical option for selected cases in which 
LVAD thrombosis occurred during the LVAD weaning process.  Consideration of 
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this option in our case may also have been well tolerated and resulted in similar 
success with elimination of hemolysis as LVAD isolation is similarly accomplished.   
Conclusion 
In summary, we describe Heartmate II outflow graft ligation (LVAD isolation) and 
reversion to medical management of heart failure as a feasible short-term option to 
eliminate LVAD associated hemolysis and permit renal recovery.   
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